Senate Files

Bills

S. 2085 118th Congress

Medicare Multi-Cancer Early Detection Screening Coverage Act

Latest action, Jun 21, 2023: Read twice and referred to the Committee on Finance.

How the Senate voted

The Senate hasn't taken a roll call on this bill in the Congresses covered.

64 cosponsors

Sponsored by Mike Crapo (Republican). Cosponsors by party, House members included:

  • Democrats
  • Republicans
  • Independents
Cosponsors
35 D · 27 R · 2 I
  • Democrat
  • Republican
  • Independent
64 senators cosponsoring

Referred to: Senate: Finance Committee

Who lobbied on it

Clients whose quarterly lobbying reports named it, each quarter.

22 clientsQ2 2023Q4 2024

The clients with the most reports naming it. A report's amount covers all of that client's lobbying in the quarter, not just this bill.

AMERICAN ASSOCIATION OF NURSE PRACTITIONERS
7 reports
EXACT SCIENCES
7 reports
GRAIL, INC.
AVENUE SOLUTIONS
7 reports
GRAIL, INC.
THE MCMANUS GROUP
7 reports
INTERNATIONAL ASSOCIATION OF FIRE FIGHTERS
7 reports
THE SUSAN G. KOMEN BREAST CANCER FOUNDATION, INC. DBA SUSAN G. KOMEN
7 reports
EXACT SCIENCES CORPORATION
ALPINE GROUP PARTNERS, LLC.
6 reports
GRAIL LLC
MILLER STRATEGIES, LLC
6 reports
GRAIL, INC.
BALLARD SPAHR LLP
6 reports
IPSEN BIOPHARMACEUTICALS, INC.
RICCHETTI INCORPORATED
6 reports
NATIONAL MINORITY QUALITY FORUM ACTION NETWORK
INTEGRATED SOLUTIONS GROUP
6 reports
U.S. CHAMBER OF COMMERCE INSTITUTE FOR LEGAL REFORM
HOLLIER & ASSOCIATES
6 reports
CARIS LIFE SCIENCES, INC.
SPLITOAK STRATEGIES LLC
5 reports
CHRONIC CARE POLICY ALLIANCE
5 reports
EXACT SCIENCES
THE DUBERSTEIN GROUP INC.
5 reports
All 25 of 27 clients
ClientLobbying firmReportsReports totalingFromToSenate
AMERICAN ASSOCIATION OF NURSE PRACTITIONERS7$2.6MQ4 2023Q3 2024yes
EXACT SCIENCES7$2.9MQ4 2023Q3 2024yes
GRAIL, INC.AVENUE SOLUTIONS7$0Q4 2023Q3 2024yes
GRAIL, INC.THE MCMANUS GROUP7$0Q4 2023Q3 2024yes
INTERNATIONAL ASSOCIATION OF FIRE FIGHTERS7$1.1MQ4 2023Q3 2024yes
THE SUSAN G. KOMEN BREAST CANCER FOUNDATION, INC. DBA SUSAN G. KOMEN7$540KQ4 2023Q3 2024yes
EXACT SCIENCES CORPORATIONALPINE GROUP PARTNERS, LLC.6$0Q4 2023Q3 2024yes
GRAIL LLCMILLER STRATEGIES, LLC6$0Q4 2023Q3 2024yes
GRAIL, INC.BALLARD SPAHR LLP6$0Q4 2023Q3 2024yes
IPSEN BIOPHARMACEUTICALS, INC.RICCHETTI INCORPORATED6$120KQ4 2023Q3 2024yes
NATIONAL MINORITY QUALITY FORUM ACTION NETWORKINTEGRATED SOLUTIONS GROUP6$272KQ4 2023Q3 2024yes
U.S. CHAMBER OF COMMERCE INSTITUTE FOR LEGAL REFORMHOLLIER & ASSOCIATES6$180KQ4 2023Q3 2024yes
CARIS LIFE SCIENCES, INC.SPLITOAK STRATEGIES LLC5$200KQ4 2023Q3 2024yes
CHRONIC CARE POLICY ALLIANCE5$520KQ4 2023Q3 2024yes
EXACT SCIENCESTHE DUBERSTEIN GROUP INC.5$0Q4 2023Q3 2024yes
GRAIL, INC.5$3.1MQ4 2023Q3 2024yes
GRAIL, LLCWILLIAMS AND JENSEN, PLLC5$0Q4 2023Q3 2024yes
CHRONIC CARE POLICY ALLIANCESIMS STRATEGIES, LLC4$0Q4 2023Q3 2024yes
AMERICAN CANCER SOCIETY CANCER ACTION NETWORK INC3$5.5MQ4 2024Q3 2024yes
ASSOCIATION OF CANCER CARE CENTERS (FKA ASSOCIATION OF COMMUNITY CANCER CENTERS)3$40KQ4 2024Q3 2024yes
EXACT SCIENCES CORPORATIONARENTFOX SCHIFF LLP3$0Q4 2023Q3 2023yes
ADAPTIVE BIOTECHNOLOGIESARNOLD & PORTER KAYE SCHOLER LLP2$90KQ2 2023Q3 2023yes
AMERICAN LUNG ASSOCIATION2$240KQ4 2024Q3 2024yes
ASTRAZENECA PHARMACEUTICALS LP2$1.8MQ2 2023Q3 2023yes
HEMATOLOGY ONCOLOGY PHARMACY ASSOCIATIONCAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.2$100KQ4 2024Q3 2024yes